Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Meridian Wealth Management LLC

Meridian Wealth Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 826 shares of the biotechnology company’s stock after purchasing an additional 81 shares during the period. Meridian Wealth Management LLC’s holdings in Axon Enterprise were worth $491,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise in the fourth quarter valued at about $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise in the fourth quarter valued at about $45,000. Prestige Wealth Management Group LLC increased its holdings in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the period. Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise in the fourth quarter valued at about $53,000. Finally, GPS Wealth Strategies Group LLC increased its holdings in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after purchasing an additional 40 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $534.96 on Thursday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a market cap of $40.79 billion, a price-to-earnings ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business’s 50 day moving average price is $605.52 and its 200 day moving average price is $527.52.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Barclays set a $726.00 target price on Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday, February 27th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.